MIRA INFORM REPORT

 

 

Report Date :

19.05.2007

 

IDENTIFICATION DETAILS

 

Name :

LIFECARE DEVICES PRIVATE LIMITED

 

 

Registered Office :

117 Creative Industrial Building, Sunder Nagar, Kalina, Santacruz (East), Mumbai – 400098

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

03.09.1996

 

 

Com. Reg. No.:

102333

 

 

CIN No.:

[Company Identification No.]

U33114MH1996PTC102333

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in imports and marketing of Surgical & Dental Devices.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 95868

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

117 Creative Industrial Building, Sunder Nagar, Kalina, Santacruz (East), Mumbai – 400098

Tel. No.:

91-22-6185560

Fax No.:

91-22-6175979

E-Mail :

manhar11@yahoo.com

Area :

500sq.fts

Location :

Leased

 

 

Chennai Office :

38, Ground Floor, Puram Prakasam Road, Balaji Nagar, Royapettah, Chennai – 600014

Tel. No.:

91-44-30904038/ 91-9382661212

 

 

Bangalore Office :

Premier business Center, Lavelle Road, Bangalore – 560001

Tel. No.:

91-80-41246077/41246079/ 91-9342863428

 

 

Delhi Office :

21/134, Basement, Vikram Vihar, Lajpat Nagar – 4, Delhi – 110024

Tel. No.:

91-11-30929574

 

 

DIRECTORS

 

Name :

Shri Zubin Daruwalla

Designation :

Director

Address :

38, Jame Jamshed Buiding, Jame Jamshed Road, Dadar, Mumbai - 400014

Date of Birth/Age :

31 years

Qualification :

M.B.A.

Experience :

11 years

Date of Appointment :

03.09.1996

 

 

Name :

Shri Ruumi Daruwalla

Designation :

Director

Address :

38, Jame Jamshed Buiding, Jame Jamshed Road, Dadar, Mumbai - 400014

Date of Birth/Age :

35 years

Qualification :

B.E. Mech.

Experience :

15 years

Date of Appointment :

0.09.1996

 

 

Name :

Shri Jal Daruwalla

Designation :

Director

Address :

38, Jame Jamshed Buiding, Jame Jamshed Road, Dadar, Mumbai - 400014

Date of Appointment :

03.06.1996

 

 

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Mr. Zunib Jal Daruwalla

 

100

Mr. Jal Daruwalla

 

100

Mr. Ruumi Daruwalla

 

100

 

 

 

Category

 

Percentage of Holding

Directors or relative of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject  is engaged in imports and marketing of Surgical & Dental Devices.

 

 

Products :

LogiCal® Pressure Monitoring System

TranStar® Pressure Monitoring System                                                      

       Kids Kit™ Closed Blood Sampling System                                                

Clear-Cuff® Pressure Infusor                                                                    

 

 

Imports :

 

Countries :

U.S.A., U.K. and Israel.

Terms :

 

Purchasing :

L/C and Open Account terms

 

 

 

GENERAL INFORMATION

 

Customers :

¨       Wockhardt Hospital & Heart Institution

¨       Leelavati Hospital & Research Centre

¨       Siemens Limited

¨       Jaslok Hospital

¨       Dr. Ashish Kakar

¨       Breach Candy Hospital

¨       Gujarat Methodist Church

 

 

No. of Employees :

15

 

 

Bankers :

Allahabad Bank, Wadala, Mumbai – 400 031, INDIA

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Manhar Mandalia and Company

Chartered Accountants

Address :

101, Panchvati Co-Op HSG. Society, 1st Floor, Corner of S.V. Road, Bajaj Road, Kandivali (West), Mumbai – 400067, Maharashtra.

 

 

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

100000

Equity Shares

Rs.10/- each

Rs.1.000 million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000

Equity Shares

Rs.10/- each

Rs.0.100 million

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

0.100

0.100

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

23.867

15.423

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

23.967

15.523

LOAN FUNDS

 

 

 

1] Secured Loans

 

0.000

0.000

2] Unsecured Loans

 

0.911

1.316

TOTAL BORROWING

 

0.911

1.316

DEFERRED TAX LIABILITIES

 

29.016

18.614

 

 

 

 

TOTAL

 

53.894

35.453

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

2.829

0.903

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

2.817

0.809

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

0.000

0.000

 

Sundry Debtors

 

0.000

0.000

 

Cash & Bank Balances

 

1.230

2.775

 

Other Current Assets

 

33.236

10.166

 

Loans & Advances

 

13.782

20.800

Total Current Assets

 

48.248

33.741

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

0.000

0.000

 

Provisions

 

0.000

0.000

Total Current Liabilities

 

0.000

0.000

Net Current Assets

 

48.248

33.741

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

53.894

35.453

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2006

31.03.2005

Sales Turnover (including other income)

 

79.707

39.453

Total Income

 

79.707

39.453

 

 

 

 

Profit/(Loss) After Tax

 

22.243

15.098

 

 

 

 

Expenditures :

 

 

 

 

Depreciation & Amortization

 

0.404

0.249

 

Other Expenditure

 

57.464

24.354

Total Expenditure

 

57.868

24.603

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2006

31.03.2005

PAT / Total Income

(%)

 

27.90

38.26

 

 

 

 

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

LIFECARE DEVICES PRIVATE LIMITED: 1986 – LIFECARE CE: 1989 -

 

 

Subject journey saving and enchanting lives began in 1986 in Cardiac Anesthesia, Cardio – Vascular, Cancer, and orthopedic surgical devices. The demand for implants for cancer patients and for other medical specialities became a proving ground resulting in Lifecare’s specialization in dental implants and related devices utilized by the dental profession.

 

It quickly became apparent that dental implant revolutionized the practice of density and that untold millions of patients world- wide would take advantage of their benefits to enchaned quality of life and often. Life – span itself.

 

In 1989 – 90 Lifecare introduced the IMZ implant sustem in India. Soon Lifecare realized that many dentists lacked current information required to perform implant density and also include bone enchancement techniques in patient care. Today this is still true, though to a lesser extent. Therefore Lifecare rriginated a plan t take dentista out of the country t prime sources for training and at the same tome institute habds on courses throughout India. Thus began Lifecare’s journey, into education, and the formation of Lifecare CE. Today, several esteemed Indian implantologists are proud to say they trainded with LifeCare CE.

 

In 1992, LifeCare introduced the first at home tooth whitening system with Opalescene and a range of esthetic dentistry products. LifeCare is proud that thousands  of dentists were trained.

 

In 1995 subject gave up all its other products to focus on Dental implants and Bone Regeneration.

 

It has been an exciting 16 years of bringing dental implantology within the reach of the average patient. It was subject introduced the first under Rs. 3,000 implant

 

 In 1996, EZ Hi – Tec implant: a US – FDA, CE, ISO – 9002, EN – 14001 certified Implant system. The US – FDA certificate was granted in 1994.

 

In 1997, EZ HI – TEC was the first company in the world to introduce the Transitional Implant. The concept transitional implant has since evolved to clinical situations for long tem use.

 

In 2000, EZ Hi- Tec started developing a One Piece Implant concept, originally thought of by its founder Director Mr. Ruumi Daruwalla. Named the TRX –OP, this one piece system with a built on abutment was introduced following extensive clinical trials.

 

In 1997, LifeCare introduced ATR Physiodispenser in India. ATR’s unique features made it an immediate absolute favorite. The latest is ATR’s low priced Model 2000 Plus which has all the high end features including a 20:1 Implant Dentistry contra angle and variable speed control. ATR gave Lifecare the great honor of launching this new model on India first before its world wide release.

 

 

The guiding principles of subject have also introduced products that are user friendly, predictable and not technique sensitive. The concept of subject is to provide a one stop solution for your needs in Implant Dentistry.

 

These guiding principles led us to two great product lines to help solve certain current difficulties. First subject selected the Endopore implant system, introducing it in India in 1999. Sinus lifts and subantral elevation and augmentation and implant placement are all too often integral to each other. The Endopore system is very easy to utilize. Implant placement is simplified. Endopore’s unique Implant interface, sintered diffusion – bonded microsphere enable the use of shorter implant as well as less ideal bone density. Professor Lang of the University of Berne state that the two system in the world today with the finest and longest clinical data validation are Branemark and Endopore systems.

 

Next subject reintroduced Geistlich’s Bio – Oss and Bio – Gide in 2004. Easy to utilize, they have a predictable almost 100%sucess rate in bone regeneration. They are the industry gold standard.

 

Stoma instruments Germany is without doubt the world leader in instrumentation for Implant Dentistry. Osteotomes, sinus lifts sets and many others are available from subject.

 

Ultrasonic Bone Surgery (UBS) is the ultimate dram machine for dental implantologists to cut bone, to spread narrow bone I thin ridges, for sinus lifts, bone harvesting and other procedures. UBS is the newest and a revolutionary additions t subject armamentarium for the dental implantologist.

 

Subject is now going global. The first overseas office will commence service in Singapore in January 2006.

 

Subject is totally committed to Dental implantology and its advancement for the benefit of the clinician and the patient.

 

Subject CE is totally committed to provide state of the art educational opportunities to synergize the unbeatable combination of well trained practitioners utilizing valid, predictable, certified implant system and associated armamentaria.

 

The company is in trade terms with :

 

¨       Life Care Inc.

¨       Pioneer Dental

¨       Pioneer Surgical

¨       Cook South East Asia

¨       Medex Medical

¨       Space Labs Medical Inc.

¨       AVL Bio-Medical

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.40.55

UK Pound

1

Rs.80.08

Euro

1

Rs.54.58

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions